{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:56:20Z","timestamp":1795085780328,"version":"4.10.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2024NSCQMSX0342"],"award-info":[{"award-number":["CSTB2024NSCQMSX0342"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2023NSCQMSX0037"],"award-info":[{"award-number":["CSTB2023NSCQMSX0037"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82472354"],"award-info":[{"award-number":["82472354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chongqing medical scientific research project","award":["2025ZDXM016"],"award-info":[{"award-number":["2025ZDXM016"]}]},{"name":"Senior Medical Talents Program of Chongqing for Young and Middle-aged","award":["2022-15"],"award-info":[{"award-number":["2022-15"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Tumor-associated neutrophils and macrophages are key components of the hepatocellular carcinoma (HCC) microenvironment. However, the interplay between them and its contribution to HCC progression remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bioinformatic analysis of TCGA datasets and clinical HCC samples was used to evaluate neutrophil extracellular trap (NETs) levels and macrophage polarization. Co-culture of neutrophils, macrophages, and HCC cells, along with molecular analysis and in vivo mouse models, were employed to dissect the mechanisms underlying NETs-mediated macrophage reprogramming and tumor progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NETs were significantly elevated in HCC patients, particularly in advanced and metastatic stages, which were positively correlated with intrahepatic M2 macrophage infiltration and M2d subset-associated cytokines in blood. In vitro, NETs promoted M2d polarization in the presence of HCC cells via IL-17R\/NF-\u03baB signaling activated by IL-17 carried within NETs, which subsequently enhanced angiogenesis, migration, invasion, and epithelial-mesenchymal transition; these effects were partially reversed by IL-17R inhibition. In vivo, NETs-induced M2d polarization accelerated tumor growth, angiogenesis, and metastasis, whereas IL-17R blockade attenuated these pro-tumor effects. Moreover, M2d macrophages indirectly promoted NETs formation by upregulating HCC cell-derived S100A9 through VEGF-NF-\u03baB signaling, establishing a positive feedback loop between neutrophils and macrophages. Furthermore, IL-17 carried by NETs (NETs-IL-17) demonstrated strong predictive value for extrahepatic metastasis in HCC, with an area under the ROC curve (AUC) of 0.89.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A positive feedback loop between neutrophils and macrophages via the NETs-IL-17\/VEGF\/S100A9 axis accelerates HCC progression and metastasis. More importantly, NETs-IL-17 exhibited potential as an alternative biomarker for predicting extrahepatic metastasis in HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03618-x","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T19:24:39Z","timestamp":1767122679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Neutrophil-macrophage crosstalk via NETs\u2013IL-17\/VEGF\/S100A9 axis promotes hepatocellular carcinoma progression"],"prefix":"10.1186","volume":"45","author":[{"given":"Rong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-6159","authenticated-orcid":false,"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3882-7527","authenticated-orcid":false,"given":"Liang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"4","key":"3618_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410\u201320.","journal-title":"JAMA Surg"},{"issue":"1","key":"3618_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3618_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17(1):25.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3618_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01933-x","volume":"9","author":"H Wang","year":"2024","unstructured":"Wang H, Kim SJ, Lei Y, Wang S, Wang H, Huang H, et al. Neutrophil extracellular traps in homeostasis and disease. Signal Transduct Target Ther. 2024;9(1):235.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3618_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","volume":"41","author":"JM Adrover","year":"2023","unstructured":"Adrover JM, McDowell SAC, He XY, Quail DF, Egeblad M. NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell. 2023;41(3):505\u201326.","journal-title":"Cancer Cell"},{"issue":"2","key":"3618_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cac2.12388","volume":"43","author":"X Zhan","year":"2023","unstructured":"Zhan X, Wu R, Kong XH, You Y, He K, Sun XY, et al. Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4\/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma. Cancer Commun. 2023;43(2):225\u201345.","journal-title":"Cancer Commun"},{"issue":"1","key":"3618_CR7","doi-asserted-by":"publisher","first-page":"16628","DOI":"10.1038\/s41598-017-16778-4","volume":"7","author":"HH Peng","year":"2017","unstructured":"Peng HH, Liu YJ, Ojcius DM, Lee CM, Chen RH, Huang PR, et al. Mineral particles stimulate innate immunity through neutrophil extracellular traps containing HMGB1. Sci Rep. 2017;7(1):16628.","journal-title":"Sci Rep"},{"issue":"7814","key":"3618_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang L, Liu Q, Zhang X, Liu X, Zhou B, Chen J, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583(7814):133\u20138.","journal-title":"Nature"},{"issue":"1","key":"3618_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41467-022-28172-4","volume":"13","author":"AS Wilson","year":"2022","unstructured":"Wilson AS, Randall KL, Pettitt JA, Ellyard JI, Blumenthal A, Enders A, et al. Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2. Nat Commun. 2022;13(1):528.","journal-title":"Nat Commun"},{"issue":"9","key":"3618_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","volume":"20","author":"M Bied","year":"2023","unstructured":"Bied M, Ho WW, Ginhoux F, Bleriot C. Roles of macrophages in tumor development: a spatiotemporal perspective. Cell Mol Immunol. 2023;20(9):983\u201392.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3618_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s11658-022-00384-y","volume":"27","author":"AT Gharavi","year":"2022","unstructured":"Gharavi AT, Hanjani NA, Movahed E, Doroudian M. The role of macrophage subtypes and exosomes in immunomodulation. Cell Mol Biol Lett. 2022;27(1):83.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"3618_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L, et al. Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol. 2024;8(1):31.","journal-title":"NPJ Precis Oncol"},{"issue":"7","key":"3618_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41419-024-06888-z","volume":"15","author":"D Li","year":"2024","unstructured":"Li D, Zhang T, Guo Y, Bi C, Liu M, Wang G. Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma. Cell Death Dis. 2024;15(7):498.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3618_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00872-w","volume":"21","author":"Y Lu","year":"2023","unstructured":"Lu Y, Han G, Zhang Y, Zhang L, Li Z, Wang Q, et al. M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma. Cell Commun Signal. 2023;21(1):299.","journal-title":"Cell Commun Signal"},{"key":"3618_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1169560","volume":"14","author":"G Koncz","year":"2023","unstructured":"Koncz G, Jenei V, Toth M, Varadi E, Kardos B, Bacsi A, et al. Damage-mediated macrophage polarization in sterile inflammation. Front Immunol. 2023;14:1169560.","journal-title":"Front Immunol"},{"issue":"6","key":"3618_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19(6):369\u201382.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3618_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02817-8","volume":"42","author":"X Kong","year":"2023","unstructured":"Kong X, Zhang Y, Xiang L, You Y, Duan Y, Zhao Y, et al. Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression. J Exp Clin Cancer Res. 2023;42(1):236.","journal-title":"J Exp Clin Cancer Res"},{"key":"3618_CR18","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.2147\/CMAR.S174899","volume":"10","author":"J Shen","year":"2018","unstructured":"Shen J, Sun X, Pan B, Cao S, Cao J, Che D, et al. IL-17 induces macrophages to M2-like phenotype via NF-kappaB. Cancer Manage Res. 2018;10:4217\u201328.","journal-title":"Cancer Manage Res"},{"key":"3618_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4286364","volume":"2018","author":"D Shen","year":"2018","unstructured":"Shen D, Chu F, Lang Y, Geng Y, Zheng X, Zhu J, et al. Beneficial or harmful role of macrophages in Guillain-Barre syndrome and experimental autoimmune neuritis. Mediators Inflamm. 2018;2018:4286364.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"3618_CR20","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.neuron.2014.07.027","volume":"83","author":"A Kroner","year":"2014","unstructured":"Kroner A, Greenhalgh AD, Zarruk JG, Passos Dos Santos R, Gaestel M, David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron. 2014;83(5):1098\u2013116.","journal-title":"Neuron"},{"issue":"1","key":"3618_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01620-3","volume":"8","author":"L Huangfu","year":"2023","unstructured":"Huangfu L, Li R, Huang Y, Wang S. The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther. 2023;8(1):402.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3618_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41419-018-0512-2","volume":"9","author":"L Duan","year":"2018","unstructured":"Duan L, Wu R, Zhang X, Wang D, You Y, Zhang Y, et al. HBx-induced S100A9 in NF-kappaB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells. Cell Death Dis. 2018;9(6):629.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3618_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/CIRCULATIONAHA.118.034165","volume":"139","author":"VC Ganta","year":"2019","unstructured":"Ganta VC, Choi M, Farber CR, Annex BH. Antiangiogenic VEGF(165)b regulates macrophage polarization via S100A8\/S100A9 in peripheral artery disease. Circulation. 2019;139(2):226\u201342.","journal-title":"Circulation"},{"issue":"12","key":"3618_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006;8(12):1369\u201375.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"3618_CR25","doi-asserted-by":"publisher","first-page":"e12929","DOI":"10.1111\/cpr.12929","volume":"54","author":"J Tu","year":"2021","unstructured":"Tu J, Fang Y, Han D, Tan X, Jiang H, Gong X, et al. Activation of nuclear factor-kappaB in the angiogenesis of glioma: insights into the associated molecular mechanisms and targeted therapies. Cell Prolif. 2021;54(2):e12929.","journal-title":"Cell Prolif"},{"issue":"1","key":"3618_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3618_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02036-z","volume":"40","author":"L Ronchetti","year":"2021","unstructured":"Ronchetti L, Boubaker NS, Barba M, Vici P, Gurtner A, Piaggio G. Neutrophil extracellular traps in cancer: not only catching microbes. J Exp Clin Cancer Res. 2021;40(1):231.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3618_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2020.04.009","volume":"52","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Oliver TG. Neutrophils create an impenetrable shield between tumor and cytotoxic immune cells. Immunity. 2020;52(5):729\u201331.","journal-title":"Immunity"},{"key":"3618_CR29","doi-asserted-by":"publisher","first-page":"785222","DOI":"10.3389\/fimmu.2021.785222","volume":"12","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier C, Yazdani HO, Morder K, Geller DA, Simmons RL, Tohme S. Neutrophil extracellular traps promote T cell exhaustion in the tumor microenvironment. Front Immunol. 2021;12:785222.","journal-title":"Front Immunol"},{"issue":"8","key":"3618_CR30","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.4049\/jimmunol.1800159","volume":"203","author":"B Lazzaretto","year":"2019","unstructured":"Lazzaretto B, Fadeel B. Intra- and extracellular degradation of neutrophil extracellular traps by macrophages and dendritic cells. J Immunol. 2019;203(8):2276\u201390.","journal-title":"J Immunol"},{"issue":"1","key":"3618_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01944-9","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wu R, Zhan X, Wang XY, Xiang LW, Duan YQ, et al. Neutrophil extracellular traps facilitate liver inflammation\/fibrosis progression by entering macrophages and triggering AIM2 inflammasome-dependent pyroptosis. Cell Commun Signal. 2024;22(1):556.","journal-title":"Cell Commun Signal"},{"key":"3618_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.freeradbiomed.2024.09.009","volume":"224","author":"H Tan","year":"2024","unstructured":"Tan H, Zhang S, Zhang Z, Zhang J, Wang Z, Liao J, et al. Neutrophil extracellular traps promote M1 macrophage polarization in gouty inflammation via targeting hexokinase-2. Free Radic Biol Med. 2024;224:540\u201353.","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"3618_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1158\/1535-7163.MCT-23-0660","volume":"23","author":"YT Liu","year":"2024","unstructured":"Liu YT, Mao ZW, Ding Y, Wang WL. Macrophages as targets in hepatocellular carcinoma therapy. Mol Cancer Ther. 2024;23(6):780\u201390.","journal-title":"Mol Cancer Ther"},{"key":"3618_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.760971","volume":"11","author":"J Xu","year":"2021","unstructured":"Xu J, Lin H, Wu G, Zhu M, Li M. IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front Oncol. 2021;11:760971.","journal-title":"Front Oncol"},{"issue":"3","key":"3618_CR35","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","volume":"25","author":"MA Morse","year":"2019","unstructured":"Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, et al. The role of angiogenesis in hepatocellular carcinoma. Clin Cancer Res. 2019;25(3):912\u201320.","journal-title":"Clin Cancer Res"},{"key":"3618_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660944","volume":"12","author":"N Bannoud","year":"2021","unstructured":"Bannoud N, Dalotto-Moreno T, Kindgard L, Garcia PA, Blidner AG, Marino KV, et al. Hypoxia supports differentiation of terminally exhausted CD8 T cells. Front Immunol. 2021;12:660944.","journal-title":"Front Immunol"},{"issue":"7","key":"3618_CR37","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.bjc.6604965","volume":"100","author":"C Alfaro","year":"2009","unstructured":"Alfaro C, Suarez N, Gonzalez A, Solano S, Erro L, Dubrot J, et al. Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer. 2009;100(7):1111\u20139.","journal-title":"Br J Cancer"},{"key":"3618_CR38","doi-asserted-by":"publisher","first-page":"616837","DOI":"10.3389\/fimmu.2021.616837","volume":"12","author":"M Bourhis","year":"2021","unstructured":"Bourhis M, Palle J, Galy-Fauroux I, Terme M. Direct and indirect modulation of T cells by VEGF-A counteracted by anti-angiogenic treatment. Front Immunol. 2021;12:616837.","journal-title":"Front Immunol"},{"issue":"1","key":"3618_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","volume":"24","author":"S He","year":"2025","unstructured":"He S, Zheng L, Qi C. Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy. Mol Cancer. 2025;24(1):5.","journal-title":"Mol Cancer"},{"issue":"1","key":"3618_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-32-3","volume":"32","author":"R Liao","year":"2013","unstructured":"Liao R, Sun J, Wu H, Yi Y, Wang JX, He HW, et al. High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. Journal of experimental & clinical cancer research\u202f: CR. 2013;32(1):3.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"3618_CR41","doi-asserted-by":"crossref","unstructured":"Zhou X, Qiao C, Chu X, Yang Y, Man H, Liu J et al. S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3\/PD-L1 pathway. Cell Oncol. 2025.","DOI":"10.21203\/rs.3.rs-5797937\/v1"},{"issue":"7","key":"3618_CR42","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gutjnl-2024-333944","volume":"74","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Huang W, Hu D, Jiang J, Zhang J, Wu Z, et al. E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression. Gut. 2025;74(7):1137\u201349.","journal-title":"Gut"},{"issue":"Suppl 2","key":"3618_CR43","doi-asserted-by":"publisher","first-page":"ii116","DOI":"10.1136\/annrheumdis-2012-202371","volume":"72","author":"DD Patel","year":"2013","unstructured":"Patel DD, Lee DM, Kolbinger F, Antoni C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis. 2013;72(Suppl 2):ii116-23.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3618_CR44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2468-1253(23)00147-4","volume":"8","author":"M Pinter","year":"2023","unstructured":"Pinter M, Scheiner B, Pinato DJ. Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice. Lancet Gastroenterol Hepatol. 2023;8(8):760\u201370.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"3618_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-02985-1","volume":"43","author":"X Tu","year":"2024","unstructured":"Tu X, Chen L, Zheng Y, Mu C, Zhang Z, Wang F, et al. S100A9(+)CD14(+) monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function. Journal of Experimental & Clinical Cancer Research. 2024;43(1):72.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"11","key":"3618_CR46","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.trecan.2021.07.001","volume":"7","author":"E Schuster","year":"2021","unstructured":"Schuster E, Taftaf R, Reduzzi C, Albert MK, Romero-Calvo I, Liu H. Better together: circulating tumor cell clustering in metastatic cancer. Trends Cancer. 2021;7(11):1020\u201332.","journal-title":"Trends Cancer"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03618-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T10:03:43Z","timestamp":1769681023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03618-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3618"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03618-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University in agreement with the Declaration of Helsinki (No. 2024\u2009\u2212\u2009316). All animal procedures were approved by the Animal Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University (Approval No. IACUC-SAHCQMU-2024-00065).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final version of the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}